Autoimmune pancreatitis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Iqra Qamar (talk | contribs) |
Iqra Qamar (talk | contribs) |
||
Line 12: | Line 12: | ||
***Extensive fibrosis | ***Extensive fibrosis | ||
***Lymphoplasmacytic infiltration | ***Lymphoplasmacytic infiltration | ||
* Endoscopic ultrasound-guided trucut biopsy (EUS-TCB) is usually avoided due to; | |||
** Increased risk of complications | |||
** Limited diagnostic ability due to | |||
*** Small sample size | |||
*** Lack of tissue architecture | |||
==References== | ==References== |
Revision as of 16:34, 5 January 2018
Autoimmune pancreatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Autoimmune pancreatitis other diagnostic studies On the Web |
American Roentgen Ray Society Images of Autoimmune pancreatitis other diagnostic studies |
Autoimmune pancreatitis other diagnostic studies in the news |
Risk calculators and risk factors for Autoimmune pancreatitis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Other diagnostic studies for autoimmune pancreatitis usually include pancreatic biopsy, which may demonstrate extensive fibrosis or lymphoplasmacytic infiltration.
Other Diagnostic Studies
- Other diagnostic studies for autoimmune pancreatitis usually include:
- Pancreatic biopsy, which demonstrates:
- Extensive fibrosis
- Lymphoplasmacytic infiltration
- Pancreatic biopsy, which demonstrates:
- Endoscopic ultrasound-guided trucut biopsy (EUS-TCB) is usually avoided due to;
- Increased risk of complications
- Limited diagnostic ability due to
- Small sample size
- Lack of tissue architecture